NSAIDs and cardiovascular risk explained
" showed that they posed a cardiovascular hazard, similar in magnitude to that resulting from being a smoker or a diabetic " 04 May 2012 PHILADELPHIA – After nearly 13 years…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
" showed that they posed a cardiovascular hazard, similar in magnitude to that resulting from being a smoker or a diabetic " 04 May 2012 PHILADELPHIA – After nearly 13 years…
Public release date: 10-May-2011 Drug regulators are protecting profits over patients, warn researchers Analysis: Opening up data at the European Medicines Agency Medicines regulators are protecting drug company profits rather…
Public release date: 11-Jan-2011 The drugs include traditional non-steroidal anti-inflammatory drugs (NSAIDS) as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors. The researchers say that doctors and…
Public release date: 2-Dec-2008 Analysis: What can we learn from drug marketing efficiency? With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever…
Public release date: 24-Mar-2008 Contact: Suzanne Wu suzanne.wu@usc.edu 213-740-0252 University of Southern California In the current issue of The RAND Journal of Economics, USC researchers provide a challenge to the…
You must be logged in to post a comment.